(Q45383714)

English

RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level

scientific article published on 10 June 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level (English)

1 reference

Europe PubMed Central

14 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jinghua Ren

1

1 reference

Europe PubMed Central

14 December 2017

Wenshan He

2

1 reference

Europe PubMed Central

14 December 2017

Ruiguang Zhang

3

1 reference

Europe PubMed Central

14 December 2017

Zhenyu Li

4

1 reference

Europe PubMed Central

14 December 2017

Wenmiao Cao

5

1 reference

Europe PubMed Central

14 December 2017

Jie Yao

6

1 reference

Europe PubMed Central

14 December 2017

Fang Zhu

7

1 reference

Europe PubMed Central

14 December 2017

Tao Zhang

8

1 reference

Europe PubMed Central

14 December 2017

Gang Wu

9

1 reference

Europe PubMed Central

14 December 2017

publication date

10 June 2009

1 reference

Europe PubMed Central

14 December 2017

Journal of Huazhong University of Science and Technology. Medical Sciences

1 reference

Europe PubMed Central

14 December 2017

29

1 reference

Europe PubMed Central

14 December 2017

309-312

1 reference

Europe PubMed Central

14 December 2017

3

1 reference

Europe PubMed Central

14 December 2017

https://scigraph.springernature.com/pub.10.1007/s11596-009-0309-8

0 references

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11596-009-0309-8

21 January 2018

Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted screening of SiRNA directed HBV polymerase gene for effective inhibition of HBV expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19513612

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11596-009-0309-8

1 reference

Europe PubMed Central

14 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45383714&oldid=2076287991"